Selected research
Market Outlook & Growth Opportunities
Global Iobitrol Injection Market Outlook and Growth Opportunities 2026
Market perspective
The global Iobitrol Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iobitrol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Iobitrol Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Iobitrol Injection market include Guerbet, Brilliant Pharmaceutical and Shenghuaxi Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iobitrol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iobitrol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iobitrol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iobitrol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Iobitrol Injection Segment by Company
Guerbet
Brilliant Pharmaceutical
Shenghuaxi Pharmaceutical
Iobitrol Injection Segment by Type
75ml
50ml
100ml
Iobitrol Injection Segment by Application
Hospital
Clinic
Others
Iobitrol Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Iobitrol Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Iobitrol Injection market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Iobitrol Injection significant trends, drivers, influence factors in global and regions.
6. To analyze Iobitrol Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iobitrol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iobitrol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iobitrol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iobitrol Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iobitrol Injection industry.
Chapter 3: Detailed analysis of Iobitrol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Iobitrol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Iobitrol Injection in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 75ml
- 50ml
- 100ml
Applications
- Hospital
- Clinic
- Others
Companies covered
- Guerbet
- Brilliant Pharmaceutical
- Shenghuaxi Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Iobitrol Injection Sales Value (2021-2032)
- 1.2.2 Global Iobitrol Injection Sales Volume (2021-2032)
- 1.2.3 Global Iobitrol Injection Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Iobitrol Injection Market Dynamics
- 2.1 Iobitrol Injection Industry Trends
- 2.2 Iobitrol Injection Industry Drivers
- 2.3 Iobitrol Injection Industry Opportunities and Challenges
- 2.4 Iobitrol Injection Industry Restraints
3 Iobitrol Injection Market by Company
- 3.1 Global Iobitrol Injection Company Revenue Ranking in 2025
- 3.2 Global Iobitrol Injection Revenue by Company (2021-2026)
- 3.3 Global Iobitrol Injection Sales Volume by Company (2021-2026)
- 3.4 Global Iobitrol Injection Average Price by Company (2021-2026)
- 3.5 Global Iobitrol Injection Company Ranking (2024-2026)
- 3.6 Global Iobitrol Injection Company Manufacturing Base and Headquarters
- 3.7 Global Iobitrol Injection Company Product Type and Application
- 3.8 Global Iobitrol Injection Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Iobitrol Injection Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Iobitrol Injection Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Iobitrol Injection Market by Type
- 4.1 Iobitrol Injection Type Introduction
- 4.1.1 75ml
- 4.1.2 50ml
- 4.1.3 100ml
- 4.2 Global Iobitrol Injection Sales Volume by Type
- 4.2.1 Global Iobitrol Injection Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iobitrol Injection Sales Volume by Type (2021-2032)
- 4.2.3 Global Iobitrol Injection Sales Volume Share by Type (2021-2032)
- 4.3 Global Iobitrol Injection Sales Value by Type
- 4.3.1 Global Iobitrol Injection Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iobitrol Injection Sales Value by Type (2021-2032)
- 4.3.3 Global Iobitrol Injection Sales Value Share by Type (2021-2032)
5 Iobitrol Injection Market by Application
- 5.1 Iobitrol Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Iobitrol Injection Sales Volume by Application
- 5.2.1 Global Iobitrol Injection Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iobitrol Injection Sales Volume by Application (2021-2032)
- 5.2.3 Global Iobitrol Injection Sales Volume Share by Application (2021-2032)
- 5.3 Global Iobitrol Injection Sales Value by Application
- 5.3.1 Global Iobitrol Injection Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iobitrol Injection Sales Value by Application (2021-2032)
- 5.3.3 Global Iobitrol Injection Sales Value Share by Application (2021-2032)
6 Iobitrol Injection Regional Sales and Value Analysis
- 6.1 Global Iobitrol Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iobitrol Injection Sales by Region (2021-2032)
- 6.2.1 Global Iobitrol Injection Sales by Region: 2021-2026
- 6.2.2 Global Iobitrol Injection Sales by Region (2027-2032)
- 6.3 Global Iobitrol Injection Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Iobitrol Injection Sales Value by Region (2021-2032)
- 6.4.1 Global Iobitrol Injection Sales Value by Region: 2021-2026
- 6.4.2 Global Iobitrol Injection Sales Value by Region (2027-2032)
- 6.5 Global Iobitrol Injection Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Iobitrol Injection Sales Value (2021-2032)
- 6.6.2 North America Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Iobitrol Injection Sales Value (2021-2032)
- 6.7.2 Europe Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Iobitrol Injection Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Iobitrol Injection Sales Value (2021-2032)
- 6.9.2 South America Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Iobitrol Injection Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Iobitrol Injection Sales Value Share by Country, 2025 VS 2032
7 Iobitrol Injection Country-level Sales and Value Analysis
- 7.1 Global Iobitrol Injection Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Iobitrol Injection Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Iobitrol Injection Sales by Country (2021-2032)
- 7.3.1 Global Iobitrol Injection Sales by Country (2021-2026)
- 7.3.2 Global Iobitrol Injection Sales by Country (2027-2032)
- 7.4 Global Iobitrol Injection Sales Value by Country (2021-2032)
- 7.4.1 Global Iobitrol Injection Sales Value by Country (2021-2026)
- 7.4.2 Global Iobitrol Injection Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.9.2 France Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.16.2 China Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.19.2 India Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Iobitrol Injection Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Iobitrol Injection Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Iobitrol Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Guerbet
- 8.1.1 Guerbet Company Information
- 8.1.2 Guerbet Business Overview
- 8.1.3 Guerbet Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Guerbet Iobitrol Injection Product Portfolio
- 8.1.5 Guerbet Recent Developments
- 8.2 Brilliant Pharmaceutical
- 8.2.1 Brilliant Pharmaceutical Company Information
- 8.2.2 Brilliant Pharmaceutical Business Overview
- 8.2.3 Brilliant Pharmaceutical Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Brilliant Pharmaceutical Iobitrol Injection Product Portfolio
- 8.2.5 Brilliant Pharmaceutical Recent Developments
- 8.3 Shenghuaxi Pharmaceutical
- 8.3.1 Shenghuaxi Pharmaceutical Company Information
- 8.3.2 Shenghuaxi Pharmaceutical Business Overview
- 8.3.3 Shenghuaxi Pharmaceutical Iobitrol Injection Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Shenghuaxi Pharmaceutical Iobitrol Injection Product Portfolio
- 8.3.5 Shenghuaxi Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iobitrol Injection Value Chain Analysis
- 9.1.1 Iobitrol Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iobitrol Injection Sales Mode & Process
- 9.2 Iobitrol Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iobitrol Injection Distributors
- 9.2.3 Iobitrol Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst